AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
_6ff029a61766633234293.png?format=webp&width=1186&height=250)
Apollo Healthtech to List by 2027: Promoters to Remain in Charge
ByAinvest
Tuesday, Aug 12, 2025 8:58 pm ET1min read
Apollo Healthtech, the demerged business of Apollo Hospitals, is targeting a listing by January-March 2027. The company's CFO, Krishnan Akhileswaran, said there are no plans for a family reorganization, and the promoters will remain directors in the new company. Apollo Hospitals posted a 42% on-year rise in Q1 consolidated net profit to ₹433 crore, driven by double-digit growth in all business segments.
Apollo Healthtech, the demerged business of Apollo Hospitals, is targeting a listing by January-March 2027. The company's CFO, Krishnan Akhileswaran, confirmed that there are no plans for a family reorganization, and the promoters will remain directors in the new company. Apollo Hospitals posted a 42% on-year rise in Q1 consolidated net profit to ₹433 crore, driven by double-digit growth in all business segments [1].In addition to its strong financial performance, Apollo Healthtech is also investing heavily in artificial intelligence (AI) capabilities. The company plans to double its investment in AI over the next two to three years. This investment includes developing AI tools to read X-rays, scan reports, and even predict the risk of liver fibrosis. Apollo Healthtech has partnered with Microsoft to develop these AI-based tools, which are currently in the early stages of testing [2].
The company's focus on AI is part of a broader strategy to improve patient diagnosis and decisions related to medical procedures. This investment aligns with the growing trend among large private hospital chains in India to adopt AI technologies to enhance their services. Apollo Healthtech's overall bed capacity is expected to increase by 4,370 beds over the next 3-4 years through acquisitions, new hospitals, and expansions of existing facilities.
Apollo Healthtech's Q1 total revenue rose by 15% to ₹58.42 billion, beating estimates of ₹57.44 billion. The company expects double-digit revenue growth for the current financial year. Despite a dip in overall occupancy rates, in-patient volume grew by 3% and average revenue per in-patient increased by 9% [1].
References:
[1] https://www.reuters.com/world/india/indias-apollo-hospitals-double-ai-investments-beats-profit-estimate-2025-08-12/
[2] https://www.reuters.com/world/india/apollo-hospitals-q1-profit-rises-strong-demand-2025-08-12/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet